Management of HCV-related decompensated cirrhosis with direct-acting antiviral agents: who should be treated?

Background Medical treatment of decompensated cirrhosis due to hepatitis C virus (HCV) remains a clinical challenge even in the era of direct-acting antiviral drugs (DAAs). We evaluated the efficacy and safety of DAAs in the management of HCV genotype 4-related decompensated cirrhosis. Methods The s...

Ausführliche Beschreibung